Introducing MyoVista

MyoVista screening targets the leading cause of death and largest spending area within modern day healthcare. MyoVista is a simple, non-invasive medical device that provides medical practitioners comprehensive information to screen for heart disease.



The MyoVista Waveform

Clinical trials are underway comparing the Myovista to other traditional screening tests.

MyoVista Display Formats

Each Myovista color waveform maps to a specific ECG line segment


MyoVista 2D Color Waveform Compared to ECG

HeartTestLabs-Print-ComparisonGraph (00000002)

Ventricular Index

MyoVista Ventricular Index

This index displays composite indexes of late and early myocardial repolarization of the left and right ventricles. This allows direct comparison of left and right ventricular energy conduction as well as a ratio-metric analysis of the average energy expended.


MyoVista Energy Category Icon

The MyoVista proprietary algorithm classifies patients into three categories taking into account factors such as sex and age.
High High energy
ModerateModerate Energy
Low Low Energy

MyoVista Questions & Answers

What is the difference between a 12 lead ECG device and the MyoVista?
Like a conventional ECG, MyoVista provides standard 12 lead ECG trace and automatic interpretive analysis but also has an innovative and intuitive new user interface that employs advanced touch screen capabilities along with a large, high definition screen to make tests simple and easy to perform and review.

Is the MyoVista an at rest test?
Yes, the MyoVista is an at rest test just like a standard 12 lead ECG at rest test. The electrode placement protocol is the same as a standard 12 lead ECG.

Who can perform and interpret a MyoVista Test
The MyoVista is designed to be a front line screening test that can be performed and interpreted by a general practitioner.